NON-SMALL-CELL LUNG CARCINOMA
Clinical trials for NON-SMALL-CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL-CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL-CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo therapy for advanced cancers shows early safety data
Disease control TerminatedThis early-phase study tested a new drug called TNO155 combined with either spartalizumab or ribociclib in 122 adults with advanced solid tumors (lung, head and neck, esophageal, stomach, and colorectal cancers). The main goal was to check safety and find the right dose. The stud…
Matched conditions: NON-SMALL-CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 17, 2026 01:11 UTC
-
Experimental cancer drug trial halted early – what we know
Disease control TerminatedThis early-stage study tested an experimental pill called PRT7732 in people with advanced solid tumors that have a specific genetic change (SMARCA4 mutation). The main goals were to check safety, find the right dose, and see if the drug shrinks tumors. The study was terminated ea…
Matched conditions: NON-SMALL-CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Experimental cancer pill fails to launch: early trial halted
Disease control TerminatedThis early-stage study tested an experimental oral drug called IK-595 in 75 adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have specific RAS or RAF gene mutations. The goal was to see if the drug is safe and how the body processes it. The stu…
Matched conditions: NON-SMALL-CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated Jun 02, 2026 11:40 UTC